A drug called ustekinumab significantly improved symptoms for patients with moderate to severe Crohn’s disease, according to Northwestern Medicine clinical trials published in the New England Journal of Medicine.
Browsing: Clinical Breakthroughs
The absence of obesity, diabetes and hypertension in middle age was associated with significantly fewer years lived with heart failure, according to a Northwestern Medicine study.
Northwestern’s Cancer Survivorship Institute addresses the medical, psychological and social challenges patients face after their cancer is gone.
Coronary artery calcium — a sign of atherosclerosis — was found in more than one-third of women previously considered to be low-risk for heart disease, according to a Northwestern Medicine study.
Northwestern investigators want to know why some people are immune to age-related cognitive decline. Their answers could inform future therapies for neurodegenerative diseases like Alzheimer’s.
Through pioneering research in oncofertility, reproductive endocrinologist Teresa Woodruff, PhD, offers young cancer survivors options to have children.
Standard guidelines are needed for prescribing opioids to children discharged after a sickle cell disease pain episode, according to a recent Northwestern Medicine study.
A Northwestern research team has developed a first-of-its-kind flexible microfluidic device that adheres to the skin and measures the wearer’s sweat.
Two HIV-associated cancers are less common since the advent of antiretroviral therapy, but still occur in patients with controlled HIV, according to a Northwestern Medicine study.
Patients with pacemakers or defibrillators who experience only short episodes of atrial fibrillation are not at an increased risk for stroke, according to a Northwestern Medicine study.